ERCC6 and Cockayne syndrome: The latter is in accordance to a previous work in which CRISPR/Cas9‐mediated gene correction of Cockayne syndrome‐causing ERCC6 mutations in iPSCs further differentiated into MSCs (resulting from no or very low, respectively, to considerable CSB expression levels) has been shown to rescue the cells from senescence (Wang et al., 2020).